Storm Lake Capital

Storm Lake Capital, LLC is a private equity and venture capital firm established in 2007 and headquartered in Troy, Michigan. The firm specializes in incubating and investing in various stages of companies, from seed and startup to mature and distressed assets, primarily focusing on lower middle-market businesses. It targets manufacturing, distribution, and service sectors, with a particular emphasis on metal-forming industries such as automotive, agriculture, aerospace, and heavy equipment. Storm Lake Capital typically invests between $1 million and $10 million in companies with revenues ranging from $10 million to $100 million and EBITDA between $1 million and $20 million. The firm engages in a variety of investment strategies, including minority and majority stakes, management buyouts, and growth funding, and it seeks to maintain an active role on the boards of its portfolio companies. Storm Lake Capital employs its own capital for investments and operates primarily in the Midwest and Central United States.

Alex Boosalis

Co-Founder and Partner

Todd Carlson

Co-Founder and Partner

Scott Ronan

Partner

2 past transactions

SciTech Development

Venture Round in 2024
SciTech Development LLC is a biopharmaceutical company based in Grosse Pointe Farms, Michigan, founded in 2001. The company specializes in developing oncology drugs, with a focus on safer and more effective drug delivery methods. Its proprietary Drug Delivery Platform utilizes nanovesicles to encapsulate medications, allowing cancer cells to absorb the drugs more efficiently. One of its key products is ST-001, a triglyceride-free formulation aimed at treating T-cell lymphoma, small cell lung cancer, and other diseases with limited treatment options. Additionally, SciTech Development has developed a patented drug candidate, ST-001-nanoFenretinide, which combines their delivery platform with fenretinide, an anticancer agent. The company also operates a laboratory in Baltimore, Maryland, and a manufacturing facility in Buies Creek, North Carolina.

SciTech Development

Venture Round in 2023
SciTech Development LLC is a biopharmaceutical company based in Grosse Pointe Farms, Michigan, founded in 2001. The company specializes in developing oncology drugs, with a focus on safer and more effective drug delivery methods. Its proprietary Drug Delivery Platform utilizes nanovesicles to encapsulate medications, allowing cancer cells to absorb the drugs more efficiently. One of its key products is ST-001, a triglyceride-free formulation aimed at treating T-cell lymphoma, small cell lung cancer, and other diseases with limited treatment options. Additionally, SciTech Development has developed a patented drug candidate, ST-001-nanoFenretinide, which combines their delivery platform with fenretinide, an anticancer agent. The company also operates a laboratory in Baltimore, Maryland, and a manufacturing facility in Buies Creek, North Carolina.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.